|
|
|
|
|
by hyperbovine
3706 days ago
|
|
Elsevier own some really high profile journals, including The Lancet and Cell. Refusing to publish in these journals, or similar ones in terms of impact factor, is simply not an option for junior faculty in most departments. I have friends for whom "publishing in Nature, Science and/or Cell" is literally a precondition for getting tenure. |
|
Doesn't seem like the journals actually provide much beyond asking professors to do stuff for free, both in terms of writing papers and reviewing them. Is inertia really worth letting them leech so much money and lock down access (antithetical to the whole idea of public-ation...) while they're at it?